Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
145.2 EUR | +0.48% | -1.53% | -7.87% |
Apr. 26 | Transcript : IMCD N.V., Q1 2024 Earnings Call, Apr 26, 2024 | |
Apr. 24 | IMCD's Spanish Unit to Buy Cobapharma | MT |
Sales 2024 * | 4.76B 5.16B | Sales 2025 * | 5.06B 5.47B | Capitalization | 8.22B 8.9B |
---|---|---|---|---|---|
Net income 2024 * | 295M 319M | Net income 2025 * | 328M 355M | EV / Sales 2024 * | 1.98 x |
Net Debt 2024 * | 1.2B 1.3B | Net Debt 2025 * | 990M 1.07B | EV / Sales 2025 * | 1.82 x |
P/E ratio 2024 * |
28.2
x | P/E ratio 2025 * |
25.5
x | Employees | - |
Yield 2024 * |
1.55% | Yield 2025 * |
1.64% | Free-Float | 98.13% |
Latest transcript on IMCD N.V.
1 day | -2.33% | ||
1 week | -0.62% | ||
Current month | +1.55% | ||
1 month | -7.20% | ||
3 months | +3.66% | ||
6 months | +7.96% | ||
Current year | -8.31% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | 20-06-29 | |
Hans Kooijmans
DFI | Director of Finance/CFO | 63 | 11-02-28 |
Marcus Jordan
COO | Chief Operating Officer | 50 | 97-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 18-05-08 | |
Amy Motto
BRD | Director/Board Member | 52 | 20-06-29 |
Willem Eelman
BRD | Director/Board Member | 60 | 22-05-01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.06% | 304 M€ | +16.38% | ||
0.37% | 17 M€ | +7.01% | - | |
0.21% | 2 M€ | +11.20% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 145.2 | +0.48% | 5 933 |
24-05-14 | 144.4 | -2.33% | 119,985 |
24-05-13 | 147.9 | +0.41% | 74,465 |
24-05-10 | 147.3 | -0.30% | 77,243 |
24-05-09 | 147.8 | +0.24% | 47,625 |
Real-time Euronext Amsterdam, May 15, 2024 at 03:41 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.31% | 8.89B | |
+25.11% | 1.08B | |
+13.90% | 184M | |
+50.00% | 158M | |
+41.46% | 148M | |
+1.35% | 112M | |
+6.45% | 87.32M |
- Stock Market
- Equities
- IMCD Stock